Although the magnitude of change was modest, these findings suggest that IL-27 may contribute to immunosuppressive mechanisms in CLL by selectively enhancing TIM-3 expression on CD8+ T cells. Here, HAVCR2 is linked to B-cell chronic lymphocytic leukemia.